| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |